“According to the research report,
the global healthcare BPO market
is expected to reach USD 755.76 Billion
by 2030 and the market is projected to grow with a
significant CAGR of 9.49% from 2022 to 2030”.
A new business intelligence report released
by Precedence Research with the title Global healthcare BPO market 2022 by Manufacturers, Type and
Application, forecast to 2030 is designed with an objective to provide a
micro-level analysis of the market. The report offers a comprehensive study of
the current state expected at the major drivers, market strategies, and key
vendors’ growth. The report presents energetic visions to conclude and study
the market size, market hopes, and competitive surroundings. The research also
focuses on the important achievements of the market, Research &
Development, and regional growth of the leading competitors operating in the
market. The current trends of the global healthcare BPO market in conjunction
with the geographical landscape of this vertical have also been included in
this report.
Get the
Sample Pages of Report@ https://www.precedenceresearch.com/sample/2014
The global healthcare BPO market is the
professional and accurate study of various business perspectives such as major
key players, key geographies, divers, restraints, opportunities, and
challenges. This global research report has been aggregated on the basis of
various market segments and sub-segments associated with the global market.
·
Note –
In order to provide more accurate market forecast, all our reports will be
updated before delivery by considering the impact of COVID-19.
MARKET
OVERVIEW BY GEOGRAPHY
The report bifurcates the geography into
North America, Europe, Asia Pacific and the rest of the world (RoW). This
section signifies the performance of the market in each region. The penetration
of the market within each region is determined through multiple channels of
research and by taking into consideration various factors such as prospective economic
or political changes, product/service penetration, and region-wide pricing
trends for the product/service, exchange rates, and the information provided by
industry experts. Both positive as well as negative changes to the market are
taken into consideration for the market estimates. The market size by geography
is derived on the basis of the weightages assigned to these markets which are
defined by shifts in the economy, ongoing market trends, demographics and
competitors.
Get Customization on this Research Report@ https://www.precedenceresearch.com/sample/2014
COUNTRY
FORECAST
The country forecast graph shows the
comprehensive analysis on country level market. It also illustrates the market
in terms of value generated from sales for the particular year. The drop down
permits the year from 2017 to 2030 to compare the values of the countries. The
country level forecast dashboard also allows comparing the data between major
contributing countries and least participant countries for the each year. This
will help client to create strategies to make the most of upcoming growth
opportunities globally. Country level growth can accountable for both
historical as well as projected market summary, since the development and
future opportunities will create market competitors to take their decision
according to the previous year’s market evolution. The country forecast data
and CAGR will help to understand countries GDP, growing population, growth
strategies of each country, and future growth potential on country level. This
will help key vendors to identify sustainable growth opportunities in new
market.
The study objectives of global market
research report:
- To analyze the global healthcare BPO market on the basis of several business
verticals such as drivers, restraints, and opportunities
- It offers detailed elaboration on the global competitive
landscape
- To get an informative data of various leading key industries
functioning across the global regions
- It offers qualitative and quantitative analysis of the global healthcare
BPO market
- It offers all-inclusive information of global market along with
its features, applications, challenges, threats, and opportunities
Market Segmentation:
By Provider Service
- Revenue Cycle
Management
- Patient
Enrolments
- Patient
Care
- Medical Transcription
- Medical Imaging
- Device Monitoring
By Payer Service
- Claims Management
- Claims Adjudication
Services
- Claims Settlement
Services
- Information Management
Services
- Claims Repricing
- Claims Investigation
Services
- Claims Indexing Services
- Fraud Detection &
Management
- Product Development &
Business Acquisition
(PDBA)
- Member
Management
- Provider
Management
- Care Management
- Integrated Front-End
Services and Back-office Operations
- Billing and accounts
management services
- HR Services
By Life Science
Service
- Manufacturing
- R&D
- Non-Clinical
Services
- Supply Chain Management
& Logistics
- Sales and Marketing
Services
- Forecasting
- Performance Reporting
- Analytics
- Research
- Marketing
- Other Non-Clinical
Services
Regional
Segmentation
- Asia-Pacific [China,
Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany,
UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United
States, Canada, Mexico]
- South America [Brazil,
Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC,
North Africa, South Africa]
The major key questions addressed
through this innovative research report:
- What are the major challenges in front of the global healthcare
BPO market?
- Who are the key vendors of the global healthcare BPO market?
- What are the leading key industries of the global healthcare
BPO market?
- Which factors are responsible for driving the global healthcare
BPO market?
- What are the key outcomes of SWOT and Porter’s five analysis?
- What are the major key strategies for enhancing global
opportunities?
- What are the different effective sales patterns?
- What will be the global market size in the forecast period?
Various players operating in the
global healthcare BPO markets are
- Accenture (Ireland)
- Access Healthcare (US)
- Akurate Management
Solutions (US)
- Cognizant (US)
- Firstsource Solutions
(India)
- GeBBS Healthcare
Solutions (US)
- Genpact (US)
- HCL Technologies
(India)
- IBM Corporation (US)
- Infosys BPM (India)
- Invensis Technologies
(India)
- IQVIA (US)
- Lonza (Switzerland)
- Mphasis (India)
- NTT Data Corporation
(Japan)
- Omega Healthcare
(India)
- Parexel International
(US)
- R1 RCM (US)
- Sutherland Global (US)
- Sykes Enterprises (US)
- Tata Consultancy
Services (India)
- UnitedHealth Group
(US)
- Wipro (India)
- WNS (Holdings) Limited
(India)
- Xerox Corporation (US)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research
Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions &
Limitations
Chapter 3. Executive
Summary
3.1. Market Snapshot
Chapter 4. Market Variables
and Scope
4.1. Introduction
4.2. Market Classification
and Scope
4.3. Industry Value Chain
Analysis
4.3.1. Raw Material
Procurement Analysis
4.3.2. Sales and
Distribution Channel Analysis
4.3.3. Downstream Buyer
Analysis
Chapter 5. COVID 19 Impact
on Healthcare BPO Market
5.1. COVID-19 Landscape:
Healthcare BPO Industry Impact
5.2. COVID 19 - Impact Assessment
for the Industry
5.3. COVID 19 Impact:
Global Major Government Policy
5.4. Market Trends and
Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics
Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces
Analysis
6.2.1. Bargaining power of
suppliers
6.2.2. Bargaining power of
buyers
6.2.3. Threat of substitute
6.2.4. Threat of new
entrants
6.2.5. Degree of
competition
Chapter 7. Competitive
Landscape
7.1.1. Company Market
Share/Positioning Analysis
7.1.2. Key Strategies
Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global
Healthcare BPO Market, By Provider Service
8.1. Healthcare BPO Market,
by Provider Service, 2022-2030
8.1.1 Revenue Cycle
Management
8.1.1.1. Market Revenue and
Forecast (2017-2030)
8.1.2. Patient Enrolments
8.1.2.1. Market Revenue and
Forecast (2017-2030)
8.1.3. Patient Care
8.1.3.1. Market Revenue and
Forecast (2017-2030)
Chapter 9. Global
Healthcare BPO Market, By Payer Service
9.1. Healthcare BPO Market,
by Payer Service, 2022-2030
9.1.1. Claims Management
9.1.1.1. Market Revenue and
Forecast (2017-2030)
9.1.2. Product Development
& Business Acquisition (PDBA)
9.1.2.1. Market Revenue and
Forecast (2017-2030)
9.1.3. Member Management
9.1.3.1. Market Revenue and
Forecast (2017-2030)
9.1.4. Provider Management
9.1.4.1. Market Revenue and
Forecast (2017-2030)
9.1.5. Care Management
9.1.5.1. Market Revenue and
Forecast (2017-2030)
9.1.6. Integrated Front-End
Services and Back-office Operations
9.1.6.1. Market Revenue and
Forecast (2017-2030)
9.1.7. Billing and accounts
management services
9.1.8.1. Market Revenue and
Forecast (2017-2030)
9.1.8. HR Services
9.1.8.1. Market Revenue and
Forecast (2017-2030)
Chapter 10. Global
Healthcare BPO Market, By Life Science Service
10.1. Healthcare BPO
Market, by Life Science Service, 2022-2030
10.1.1. Manufacturing
10.1.1.1. Market Revenue
and Forecast (2017-2030)
10.1.2. R&D
10.1.2.1. Market Revenue
and Forecast (2017-2030)
10.1.3. Non-Clinical
Services
10.1.3.1. Market Revenue
and Forecast (2017-2030)
Chapter 11. Global
Healthcare BPO Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and
Forecast, by Provider Service (2017-2030)
11.1.2. Market Revenue and
Forecast, by Payer Service (2017-2030)
11.1.3. Market Revenue and
Forecast, by Life Science Service (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.1.4.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.1.4.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.1.5. Rest of North
America
11.1.5.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.1.5.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.1.5.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.2. Europe
11.2.1. Market Revenue and
Forecast, by Provider Service (2017-2030)
11.2.2. Market Revenue and
Forecast, by Payer Service (2017-2030)
11.2.3. Market Revenue and
Forecast, by Life Science Service (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.2.4.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.2.4.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.2.5.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.2.5.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.2.6.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.2.6.3. Market Revenue and
Forecast, by Life Science Service (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.2.7.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.2.7.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.3. APAC
11.3.1. Market Revenue and
Forecast, by Provider Service (2017-2030)
11.3.2. Market Revenue and
Forecast, by Payer Service (2017-2030)
11.3.3. Market Revenue and
Forecast, by Life Science Service (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.3.4.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.3.4.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.3.5.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.3.5.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.3.6.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.3.6.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.3.7.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.3.7.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.4. MEA
11.4.1. Market Revenue and
Forecast, by Provider Service (2017-2030)
11.4.2. Market Revenue and
Forecast, by Payer Service (2017-2030)
11.4.3. Market Revenue and
Forecast, by Life Science Service (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.4.4.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.4.4.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.4.5.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.4.5.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.4.6.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.4.6.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.4.7.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.4.7.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and
Forecast, by Provider Service (2017-2030)
11.5.2. Market Revenue and
Forecast, by Payer Service (2017-2030)
11.5.3. Market Revenue and
Forecast, by Life Science Service (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.5.4.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.5.4.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue
and Forecast, by Provider Service (2017-2030)
11.5.5.2. Market Revenue
and Forecast, by Payer Service (2017-2030)
11.5.5.3. Market Revenue
and Forecast, by Life Science Service (2017-2030)
Chapter 12. Company
Profiles
12.1. Accenture (Ireland)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial
Performance
12.1.4. Recent Initiatives
12.2. Access Healthcare
(US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial
Performance
12.2.4. Recent Initiatives
12.3. Akurate Management
Solutions (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial
Performance
12.3.4. Recent Initiatives
12.4. Cognizant (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial
Performance
12.4.4. Recent Initiatives
12.5. Firstsource Solutions
(India)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial
Performance
12.5.4. Recent Initiatives
12.6. GeBBS Healthcare
Solutions (US)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial
Performance
12.6.4. Recent Initiatives
12.7. Genpact (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial
Performance
12.7.4. Recent Initiatives
12.8. HCL Technologies
(India)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial
Performance
12.8.4. Recent Initiatives
12.9. IBM Corporation (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial
Performance
12.9.4. Recent Initiatives
12.10. Infosys BPM (India)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial
Performance
12.10.4. Recent Initiatives
Chapter 13. Research
Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/2014
Our Press
Release@ https://www.precedenceresearch.com/press-releases
About us
Precedence Research is a Canada/India
based company and one of the leading providers of strategic market insights. We
offer executive-level blueprints of markets and solutions beyond flagship
surveys. Our repository covers consultation, syndicated market studies, and
customized research reports. Through our services we aim at connecting an
organization’s goal with lucrative prospects globally.
From gauging investment feasibility to
uncovering hidden growth opportunities, our market studies cover in-depth analysis,
which also is interspersed with relevant statistics. Recommendation are often
enclosed within our reports with the sole intent of enabling organizations
achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 comments:
Post a Comment